Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Feb;137(2):358-68.
doi: 10.1016/j.jaci.2015.12.1300.

International Consensus on Allergen Immunotherapy II: Mechanisms, standardization, and pharmacoeconomics

Affiliations
Review

International Consensus on Allergen Immunotherapy II: Mechanisms, standardization, and pharmacoeconomics

Marek Jutel et al. J Allergy Clin Immunol. 2016 Feb.

Abstract

This article continues the comprehensive international consensus (ICON) statement on allergen immunotherapy (AIT). The initial article also recently appeared in the Journal. The conclusions below focus on key mechanisms of AIT-triggered tolerance, requirements in allergen standardization, AIT cost-effectiveness, and regulatory guidance. Potential barriers to and facilitators of the use of AIT are described in addition to future directions. International allergy specialists representing the European Academy of Allergy and Clinical Immunology; the American Academy of Allergy, Asthma & Immunology; the American College of Allergy, Asthma and Immunology; and the World Allergy Organization critically reviewed the existing literature and prepared this summary of recommendations for best AIT practice. The authors contributed equally and reached consensus on the statements presented herein.

Keywords: International consensus; allergen standardization; allergen vaccine; allergy; cost-effectiveness; immunotherapy; marketing authorization; mechanisms; pharmacoeconomics; regulatory authorities; tolerance; unmet needs.

PubMed Disclaimer

MeSH terms